By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish on both Amazon (AMZN) and Chewy (CHWY), citing regulatory risks, slowing growth, and questionable strategic pivots.
Risk: Regulatory pressure on Amazon's Prime ecosystem and antitrust probes, as well as Chewy's heavy reliance on stock-based compensation and capital-intensive clinic strategy.
Opportunity: None identified by the panel.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The retail landscape continues to shift as e-commerce giants and niche specialists battle for consumer dollars. Investors must choose between the diversified powerhouse Amazon.com (NASDAQ:AMZN) and the pet-care specialist Chewy (NYSE:CHWY) in 2026.
Amazon dominates through a vast logistics network and its high-margin cloud division, while Chewy builds a dedicated ecosystem around recurring pet subscriptions. These companies both leverage digital convenience but offer vastly different exposure to consumer discretionary spending. Comparing them helps identify which business model aligns better with your risk tolerance and long-term investment goals.
Amazon operates a global e-commerce and cloud-services business, serving consumers, third-party sellers, and enterprise AWS customers. Within the retail stocks landscape, it continues to face regulatory scrutiny regarding Prime subscriptions and marketplace oversight. The company is also involved in a high-profile antitrust class action involving roughly 288 million members, which could influence future operations.
In 2025, revenue reached nearly $716.9 billion, representing growth of 12.4% over the prior year. The company reported a net income of roughly $77.7 billion for the same period, continuing a trend of rising profitability. This resulted in a net margin of close to 11%, which is the percentage of revenue that remains as profit after all operating and non-operating costs are paid.
As of its December 2025 balance sheet, the debt-to-equity ratio was roughly 0.4x, which compares total debt to shareholder equity to measure financial leverage. The current ratio was approximately 1.1x, comparing short-term assets to short-term liabilities to measure immediate liquidity.
Free cash flow for the period was nearly $7.7 billion, representing the cash remaining after the company covers its operating expenses and capital investments.
Chewy serves pet parents in the U.S. and Canada through its platform, offering approximately 190,000 products from 4,000 brands. The company recently expanded its physical footprint in pet healthcare by acquiring Modern Animal, adding veterinary clinical expertise and 47 planned locations. Its Autoship subscription program drives recurring revenue and maintains a nationwide fulfillment network, simplifying repeat purchases for consumers.
In 2025, revenue reached approximately $12.6 billion, representing nearly 6.2% growth as the company expanded its customer base. The company reported a net income of roughly $222.8 million for the same period, showing its ability to generate a profit in the competitive pet market. Its net margin was approximately 1.8%, the percentage of revenue retained as profit after all business expenses.
As of its February 2026 balance sheet, the debt-to-equity ratio was roughly 1.0x, while the current ratio was 0.9x, comparing short-term assets to liabilities.
Free cash flow reached nearly $562.4 million, which is the cash left over after paying for operations and capital expenditures. Note that stock-based compensation accounted for roughly 43.1% of operating cash flow, inflating reported cash generation because it is a non-cash expense added back in the cash flow statement.
Amazon faces intense competition across all major segments from rivals like Alphabet and Microsoft. Government authorities worldwide are increasing scrutiny, with the company facing a potential $2.5 billion settlement with the FTC. Geopolitical risks in markets such as China and India also pose challenges due to evolving local regulations and trade restrictions.
Chewy deals with heavy competition from Walmart and Amazon in the pet retail space. The integration of Modern Animal clinics carries execution risks and requires significant capital spending to build out new locations. Additionally, the company is vulnerable to shipping disruptions because it relies on third-party logistics providers to deliver orders to customers.
Amazon carries a lower Forward P/E ratio, which compares the stock price to future earnings estimates, while Chewy offers a lower P/S ratio, measuring price against total revenue.
| Metric | Amazon.com | Chewy | |---|---|---| | Forward P/E | 23.3x | 30.4x | | P/S ratio | 4.1x | 0.8x |
Valuation metrics sourced from Financial Modeling Prep (FMP) and may differ from other data providers.
Both companies face risks and intense competition, but overall are solidly positioned in their respective markets. Amazon has massive scale in e-commerce, while Chewy serves the niche pet supplies market.
According to the American Pet Association, Americans spent $158 billion on their pets in 2025, giving Chewy a large market to expand into. Still, I would prefer to buy Amazon primarily for its fast-growing, highly profitable cloud business.
Amazon is a more diversified business with several growing revenue streams across advertising, third-party fulfillment services, cloud, and e-commerce. Its large size hasn’t anchored its growth all that much, as it is growing revenue faster than Chewy.
Chewy’s trailing-12-month revenue grew 6.1%, slower than Amazon’s 15.8%. Amazon may continue to see higher growth, as Amazon Web Services continues to experience significant demand for compute and custom AI chips, with segment revenue up 37% year over year in the second quarter.
Relative to its momentum, Amazon appears reasonably priced for a new investment. Investors can buy the stock at a forward P/E of 23, despite analysts expecting earnings to grow at a 20% annualized rate in the coming years.
Before you buy stock in Amazon, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amazon wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $399,832! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,374,595!
Now, it’s worth noting Stock Advisor’s total average return is 968% — a market-crushing outperformance compared to 215% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of August 10, 2026. *
John Ballard has positions in Amazon. The Motley Fool has positions in and recommends Alphabet, Amazon, Chewy, Microsoft, and Walmart. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Amazon's regulatory overhang and decelerating e-commerce growth undermine the article's clear preference versus a seemingly expensive but niche-dominant Chewy."
The article pushes Amazon (AMZN) over Chewy (CHWY) citing AWS-driven 37% segment growth, superior 11% net margins vs 1.8%, faster revenue growth (15.8% TTM vs 6.1%), and a more reasonable 23.3x forward P/E. Yet it glosses over Amazon's $2.5B FTC antitrust risk on its 288M-member Prime ecosystem, ongoing global regulatory probes, and slowing core e-commerce. Chewy's 0.8x P/S looks optically cheap but its 43% SBC-adjusted FCF, sub-1x current ratio, and heavy integration spend on 47 new vet clinics signal execution risk in a maturing pet market.
If AWS AI-chip demand cools faster than consensus expects or antitrust remedies cap marketplace/Prime economics, Amazon's re-rating could stall; meanwhile Chewy's sticky Autoship model and $158B U.S. pet spend tailwind could drive faster share gains than the article admits.
"Amazon’s valuation is anchored by the high-margin scalability of AWS and advertising, making it a fundamentally superior risk-adjusted play compared to Chewy’s low-margin, capital-intensive retail model."
The article presents a false equivalence between a platform-level infrastructure play (AMZN) and a vertical-specific retailer (CHWY). Amazon’s valuation at a 23.3x forward P/E is compelling because it masks the fact that AWS is effectively subsidizing the retail segment's margin expansion. While the article highlights regulatory risks, it ignores the structural moat provided by Amazon’s advertising business, which is now a high-margin engine that Chewy simply cannot replicate. Chewy’s 1.8% net margin is razor-thin and leaves them zero room for error in a high-interest-rate environment, especially with their heavy reliance on stock-based compensation to mask true cash flow realities.
If consumer discretionary spending craters in 2026, Amazon’s massive fixed-cost logistics network could become a liability, whereas Chewy’s subscription-based 'Autoship' model offers a more resilient, defensive revenue stream.
"Both stocks are priced for perfection in mature or capital-intensive segments, and the article's AWS growth thesis ignores that regulatory risk to cloud infrastructure is asymmetrically underpriced."
This article presents a false binary. AMZN's 23.3x forward P/E against 20% EPS growth implies a PEG ratio near 1.15—not cheap. CHWY's 30.4x forward P/E on 6% revenue growth is genuinely expensive, but the article buries the real issue: CHWY's 1.8% net margin and 43% stock-based comp dilution make that valuation indefensible. The article's AWS growth claim (37% YoY) is real, but AWS already prices in that momentum. The stronger contrarian read: neither deserves a spot. AMZN's antitrust risk ($2.5B FTC settlement) could cascade into AWS regulatory pressure. CHWY's Modern Animal integration is a $1B+ capex bet on veterinary clinics—a capital-intensive, low-margin business that contradicts its subscription-software narrative.
AMZN's diversification genuinely reduces single-point-of-failure risk, and AWS's AI-chip demand could sustain 25%+ growth for years; CHWY's $158B pet market TAM is real and undermonetized versus AMZN's mature e-commerce segment.
"Regulatory headwinds and higher capital intensity threaten Amazon's margin advantage, making AMZN riskier than the article implies."
Amazon dominates by scale, but the article understates the risk. A potential FTC settlement and ongoing antitrust scrutiny could force changes that curb Prime economics and marketplace profitability, especially if regulatory pressure pushes toward fee reforms or operational restrictions. AWS remains robust, yet AI-related capex and competitive pressure from Microsoft and Google may compress margins over time. Chewy's case rests on loyalty and autoship, but its low current margins and reliance on frequent shippings with third-party logistics leave it exposed to cost shocks; Modern Animal adds capex risk. The 2026 test is profitability under tighter regulation and higher capital needs, not just growth rate.
Chewy could surprise on profitability if autoship expands to cross-sell services and if the healthcare clinics scale efficiently; meanwhile, Amazon's regulatory headwinds may prove milder than feared and AWS AI demand could keep margins more resilient than the skeptics expect.
"CHWY's clinic expansion risks converting high-ROIC subscription cash flows into low-ROIC veterinary assets."
Claude's PEG critique on AMZN is fair, but the panel collectively underweights second-order AWS pricing power. If FTC remedies fragment Prime bundling, Amazon can accelerate ad-load and AWS metering to offset. CHWY's vet-clinic capex isn't just execution risk—it's a strategic pivot that could destroy its capital-light autoship economics if utilization stays below 55%.
"Chewy's veterinary clinic expansion is a capital-intensive misstep that will likely erode its margins in a high-interest-rate environment."
Claude is right about the PEG ratio, but the panel is missing the primary catalyst for both: the cost of capital. Amazon’s 23.3x forward P/E is sustainable only if AWS maintains its AI-driven margin expansion to offset retail's regulatory drag. Conversely, Chewy’s pivot into veterinary services is a desperate attempt to manufacture a moat where none exists. If interest rates stay elevated, Chewy’s capital-intensive clinic strategy becomes a liquidity trap, not a growth engine.
"Higher rates favor cash-generative AWS over capital-intensive vet clinics—Chewy's liquidity risk is structural, not cyclical."
Gemini's cost-of-capital framing is sharp, but it cuts both ways. If rates stay elevated, Amazon's AWS cash generation actually becomes MORE valuable—it funds the regulatory drag without external financing. Chewy's clinic capex, conversely, requires either debt (expensive) or equity dilution (shareholder destruction). The real liquidity trap isn't Amazon's; it's Chewy's. Neither panelist has quantified clinic unit economics or breakeven utilization thresholds. That's the missing number.
"Chewy's clinic pivot lacks disclosed unit economics; without per-clinic capex, operating costs, and utilization breakeven, the Modern Animal bet could destroy autoship margins rather than create durable cash flow."
Claude's dismissal of CHWY's clinic capex as 'capital-intensive' overlooks the central unknown: per-clinic economics. Without disclosed capex per clinic, operating costs, utilization breakeven, and debt service, the Modern Animal bet could erode autoship margins faster than it adds durable cash flow. A 43% SBC paydown doesn't capture the capital cadence. Until Chewy provides unit economics, the CHWY thesis remains a valuation risk, not a moat.
The panel consensus is bearish on both Amazon (AMZN) and Chewy (CHWY), citing regulatory risks, slowing growth, and questionable strategic pivots.
None identified by the panel.
Regulatory pressure on Amazon's Prime ecosystem and antitrust probes, as well as Chewy's heavy reliance on stock-based compensation and capital-intensive clinic strategy.